The Precision Peptide Company (BPC) Lead Product Achieves 95.5% Purity in Independent Lab Testing, Clearing the Industry Benchmark and Advancing Toward Commercial Launch
Highlights The BPC-157 patch is a wearable, needle-free product, designed to remove the injection barrier that has historically limited consumer adoption of peptide products Results support The Precision Peptide Company Inc.'s continued progression of its lead product toward commercial launch Independent lab results confirm 95.5% chromatographic purity and a quantified 2.02 mg dose of BPC-157 per patch¹ Purity result clears the ≥95% threshold recognized across the peptide industry as the...
2026-05-19 7:00 AM EDT
The Precision Peptide Company's Chief Scientific Officer Justin Kirkland to Be Featured on The Human Upgrade with Dave Asprey
Vancouver, British Columbia--(Newsfile Corp. - May 14, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announces that Justin Kirkland, Co-Founder and Chief Scientific Officer of the Company's wholly-owned subsidiary Amino Innovations, will be featured as a guest on an upcoming episode of The Human Upgrade with Dave Asprey. The Human Upgrade, hosted...
2026-05-14 7:30 AM EDT
The Precision Peptide Company Inc. Announces Exclusive Strategic Marketing Partnership with Mixed Martial Arts Group Limited
Vancouver, British Columbia--(Newsfile Corp. - May 12, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announces that it has entered into an Exclusive Strategic Marketing Agreement (the "Strategic Marketing Agreement") dated May 8, 2026 with Mixed Martial Arts Group Limited ("MMA"), a New South Wales, Australia-based company. Under the Strategic...
2026-05-12 7:30 AM EDT
The Precision Peptide Company Nears Commercial Launch of Needle-Free BPC-157 Patch as Final Testing Advances
Vancouver, British Columbia--(Newsfile Corp. - May 7, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today provides an update on the development of its needle-free BPC-157 transdermal patch - a product designed to give consumers a frictionless route into the peptide category for the first time. The BPC-157 patch is currently in active testing, with...
2026-05-07 7:30 AM EDT
C$1.3 Million in Proceeds Received by The Precision Peptide Company from Warrant Exercises
Vancouver, British Columbia--(Newsfile Corp. - May 5, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") a publicly traded wellness company focused on advanced peptide formulations and delivery systems, announces the receipt of approximately C$1.3 million from the exercise of outstanding warrants. The proceeds strengthen the Company's balance sheet and will be used to support the continued development and expansion of its Amino Innovations platform,...
2026-05-05 7:30 AM EDT
The Precision Peptide Company Grants RSUs and Stock Options and Settles Debt
Vancouver, British Columbia--(Newsfile Corp. - May 4, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, announces the grant of restricted share units (the "RSUs") and incentive stock options (the "Options") pursuant to the Company's omnibus share incentive plan, as well as the issuance of common shares to settle outstanding indebtedness owed to a creditor...
2026-05-04 7:30 AM EDT
The Precision Peptide Company Announces Strategic Product Marketing Agreement
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") is pleased to announce that it has entered into a strategic product marketing agreement with Raw Creation, a UK-headquartered creative agency ("Raw Creation"), to provide certain social media management, creative content, editorial, paid advertising and related marketing services to the Company (the "Agreement"). Pursuant to the Agreement, Raw...
2026-04-23 8:00 AM EDT
The Precision Peptide Company Applauds FDA Action Advancing Regulatory Clarity for Peptide Therapies
Vancouver, British Columbia--(Newsfile Corp. - April 16, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a company focused on the next-generation of peptide-based products and delivery systems, commends the U.S. Food and Drug Administration (FDA) for its recent actions to advance regulatory clarity surrounding peptide substances. The FDA's decision to remove several peptides from Category 2 of bulk drug substances and refer them to further evaluation...
2026-04-16 7:30 AM EDT
The Precision Peptide Company Announces Public Relations and Consulting Services Agreement
Vancouver, British Columbia--(Newsfile Corp. - April 15, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") is pleased to announce that it has entered into agreements with i) Think Ink Marketing Data and Email Services ("Think Ink") and ii) Ouimet Consulting Inc. ("Ouimet") to provide certain investor relations services to the Company. Think Ink The Company has entered into a public relations services agreement with Think Ink (the "Think Ink Agreement")....
2026-04-15 8:00 AM EDT
The Precision Peptide Company Launches New Corporate Website and Comments on Evolving U.S. Policy in Support of Peptide-Based Therapies
Vancouver, British Columbia--(Newsfile Corp. - April 7, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a company focused on the next-generation of peptide-based products and delivery systems, today launched it's new corporate website: www.precisionpeptidecompany.com. The website will offer regular updates regarding company developments. Additionally, the Company is encouraged by recent indications from U.S. Health and Human Services Secretary, Robert...
2026-04-07 8:00 AM EDT
Pangea Announces Change of Auditor
Vancouver, British Columbia--(Newsfile Corp. - August 12, 2022) - Pangea Natural Foods Inc. (CSE: PNGA) ("Pangea" or the "Company"), a natural food company, announces that it has changed its auditors from Harbourside CPA LLP ("Former Auditor") to Baker Tilly WM LLP ("Successor Auditor"). The Former Auditor resigned as the auditor of the Company effective August 12, 2022, and the board of directors of the Company appointed the Successor Auditor as the Company's auditor effective August 12,...
2022-08-12 2:15 PM EDT